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Formation of free radicals and reactive oxygen
species (ROS) is an integral part of human metabo-
lism. The balance between the rate of ROS forma-
tion and activity of antioxidant systems is one of the
conditions of homeostasis. Complete antioxidant
ability is a result of the activity of low-molecule
antioxidants (such as α-tocopherol, L-ascorbic acid,
coumarin, quercetin) and proteins (ceruloplasmin,
ferritin, albumin, transferrin). The increase of the
rate of ROS formation and/or inhibition of the
antioxidant mechanisms lead to oxidative stress,
which is an important element of the pathogenesis of
many diseases, including neurodegenerative and
mental diseases. The conducted research concerns
chosen individual low-molecule components, the
activity or concentration of which may correlate
with the course of free radical reactions (4, 5).
β-Carboline derivatives (Tab. 1 and 2) are
potential ligands of 5-HT1A and 5-HT2A receptors.
Pro- or antioxidant properties of this group of com-
pounds may influence the antioxidant balance. It is
therefore necessary to determine if the β-carboline
derivatives influence the number of free radicals or
ROS. The study evaluating the complete antioxidant
activity of β-carboline derivatives may provide
information on antioxidant effect of the non-enzy-
matic systems, that has the ability to counteract the
ROS malfunction (formation). 
MATERIALS AND METHODS
β-Carboline derivatives were synthesized in
the Department of Organic Chemistry, Jagiellonian
University College of Medicine, KrakÛw, Poland.
Their structures were confirmed by 1H NMR and
MS spectra. Synthesis and properties of β-carboline
derivatives will be the subject of separate publica-
tion. Among the investigated compounds, a group of
optically active derivatives, which were coded as
3ñ6, was present. Antioxidant properties of β-carbo-
line derivatives were determined spectrophotometri-
cally in two tests. 
The first was DPPH (1,1-diphenyl-2-picrylhy-
drazyl hydrate) test (2). Radical scavenging DPPH
has a violet coloring, the intensity of which decreas-
es in the presence of antioxidants proportionally to
the ability to ìsweep offî free radicals by the tested
compound. 
The second, the FRAP (ferric reducing ability
of power) test, which uses the modification of
Benzie and Streinís method, was also applied to
measure the ability of β-carboline derivatives to
reduce Fe3+ ions (3, 6). At low pH, Fe3+ ions under-
go reduction to Fe2+ ions, which in the presence of
2,4,6-tripyridyl-1,3,5-triazine (TPTZ) causes the
formation of Fe2+-TPTZ complex. The FRAP
method, primarily used for blood plasma, was mod-
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capacity as indication of oxidative stress was based on ability to scavenge free radicals by DPPH (free radical
scavenging activity test) and FRAP test (2, 3). The results were compared to those of standard substances like
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ty. Substance 10 was classified as that with prooxidative activity. 
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Figure 1. β-Carboline derivatives in comparison with the standard substances in the DPPH test [%]
Figure 2. β-Carboline derivatives ñ isomeric compounds in comparison with the standard substances in the DPPH test [%]
Figure 3. FRAP [mM] concentration values (mM) for the standard and tested substances β-carboline derivatives
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Table 1. β-Carboline derivatives ñ tested compounds.
9-(2-(Piperidin-1-yl)ethyl)-9H-β- Methyl 9-[4-(dimethylamino)butyl]-9H-β-
carboline-3-carboxamide (1) carboline-3-carboxylate (2)
(2íS)-N-(1-hydroxy-2-methylpropan-2-yl)-9H-β- (3S)-N-(4-hydroxy-2-methylbutan-2-yl)-2,3,4,9-
carboline-3-carboxamide (7) tetrahydro-1H-β-carboline-3-carboxamide (8)
(R,S)-N-cyclohexyl-2,3,4,9-tetrahydro-1H-β- (R,S)-3-methyl-1-(pyridin-3-yl)-2,3,4,9-
carboline-3-carboxamide (9) tetrahydro-1H-β-carboline (10)     
ified in order to establish the influence of the β-car-
boline derivatives on the oxidative stress of DMSO
samples of antioxidant and natural compounds.
In the study, as comparative substances were
used: L-ascorbic acid (vitamin C), trolox (analogous
with vitamin E), quercetin and curcumin (polyphe-
nols). For the tested and standard compounds, solu-
tions in DMSO of the following concentrations were
prepared: 3◊10-4, 6◊10-4, 1◊10-3, 5◊10-2 and 2◊10-1
mM. The ability of β-carboline derivatives to
ìsweep offî free radicals was expressed as a per-
centage of activity (test DPPH, Fig. 1 and Fig. 2). 
In case of the FRAP method, the Fe2+ content in the
tested samples of β-carboline derivatives was calcu-
lated (test FRAP, Fig. 3 and Fig 4). 
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RESULTS AND CONCLUSIONS
It was found that β-carboline derivatives,
excluding compounds 9 and 10, in low concentra-
tions showed antioxidant properties comparable
with vitamin C, which had the weakest antioxidant
properties (Fig.1 and 2). Compound 1 at 1∑10-3 mM
concentration showed the activity similar to trolox at
5∑10-2 mM concentration. Compound 2 at 6∑10-4 mM
concentration showed 86% of the vitamin C activi-
ty. Compound 9 showed similar activity. At the
maximum concentration, the tested compounds
were strongly pro-oxidant (Fig. 1). In the DPPH
method, compound 7 showed the weakest antioxi-
dant properties among the tested compounds ñ only
26% of the trolox activity. 
Figure 4. FRAP [mM] concentration values (mM) for the standard and stereoisomeric β-carboline derivatives
Table 2. Stereoisomeric β-carboline derivatives.
(2í,3R)-N-(1-hydroxypropan-2-yl)-2,3,4,9- (2íS,3S)-N-(1-hydroxypropan-2-yl)-2,3,4,9-tetrahydro-
tetrahydro-1H-β-carboline-3-carboxamide (3) 1H-β-carboline-3-carboxamide (4) 
(2íR,3R)-N-(1-hydroxypropan-2-yl)-2,3,4,9- (2íR,3S)-N-(1-hydroxypropan-2-yl)-2,3,4,9-tetrahydro-
tetrahydro-1H-β-carboline-3-carboxamide (5) 1H-β-carboline-3-carboxamide (6)     
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Compound 8 showed the antioxidant activity at
high concentration, which decreases with diluting,
losing it in the most diluted solutions. The most
intensive activity was observed at 2∑10-1 mM con-
centration, which is an equivalent of 50% of the cur-
cumin activity. 
Compound 10 showed pro-oxidant properties
at each concentration tested. Based on the DPPH test
results, that substance was identified as a compound
with a potential pro-oxidative activity. 
Isomeric compounds: 3, 4, 5 and 6 (Fig. 2)
showed a similar antioxidant activity at the 
2∑10-1 mM concentration. It is comparable with the
activity of vitamin C at the same concentration. The
activity of the isomeric derivatives at the concentra-
tion 5∑10-2 mM was stronger than that of vitamin C
by 40% on average, except for the compound 4,
which showed the activity comparable with vitamin
C. At the lowest concentration, only compound 5
showed antioxidant properties while compounds 3,
4 and 6 at low concentrations showed weaker pro-
oxidant properties, lower than curcumin at the con-
centration 3∑10-4 mM (Fig. 2). 
Compounds: 1, 5, 6 and 8 (β-carboline deriva-
tives) showed the strongest antioxidant properties.
Compound 10 (3-methyl-1-(pyridin-3-yl)-2,3,4,9-
tetrahydro-1H-β-carboline hydrochloride) was
found to have prooxidant properties. 
FRAP method has been used in antioxidant
properties measurements. In acidic environment,
Fe3+ present in FRAP is reduced to Fe2+, possessing
intensive blue color, with maximum absorbance at
593 nm. This reaction undergoes with any sub-
stance, which exhibits reductive properties. It was
observed that addition of DMSO solution to FRAP
solution caused a change of color. Probably DMSO
solution and present in FRAP solution Fe2+ ions cre-
ated redox system, causing development of ions,
which created colored complexes with TPTZ. It may
be assumed that the amount of Fe2+ ions raised dur-
ing measurement is influenced not only by β-carbo-
line derivatives but also by DMSO, so in such cases
itís not possible to determine antioxidant properties
unambiguously.
β-Carboline derivatives reduce the amount of
cAMP, thus affecting, among others, reduced per-
meability of cell membranes and reduced (decelerat-
ed) cell oxidation and ATP synthesis. Human cells
have an antioxidant pool sufficient to counteract the
normal physiological production of ROS and other
free radicals; however, the naturally present antiox-
idant pool is not capable of counteracting an
increase in generation of ROS; in these cases, the so-
called ìoxidative stressî occurs. From the above it
can be seen that the insurgence of ìoxidative stressî
can be caused by two phenomena: the first is the
lack of antioxidant molecules, and the second is the
uncontrolled increase of ROS and free radicals,
which are able to cause irreversible oxidation.
Oxidative stress is present to a varied extent in a
number of serious diseases in man. While this does
not mean that it is the cause of these diseases, it does
testify, as confirmed by a number of studies, that
oxidative stress can have a negative influence on the
progress of some diseases, causing further damage
to the cells of an organism that is already sick. The
most popular model of a such situation is an ìoxida-
tive burstî occurring after revescularization of an
infarcted coronary heart. 
In many pathological conditions, the develop-
ment of which is connected with intensified ROS
formation and activity, a decrease of the Q10 coen-
zyme concentration in the human body occurs. In
these cases, treatment involves pharmaceutical sup-
plementation. or increased consumption of coen-
zyme Q10 with meals as well as treatment with suit-
able chemical compounds, which significantly
increase ubiquinone biosynthesis in the organism. 
β-Carboline derivatives as potential therapeutic
compounds may, perhaps, influence the synthesis of
ubiquinone and, in consequence, the generation or
inhibition of the oxidative stress.
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